BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15840382)

  • 1. Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol.
    Horn TL; Long L; Cwik MJ; Morrissey RL; Kapetanovic IM; McCormick DL
    Chem Biol Interact; 2005 Apr; 152(2-3):79-99. PubMed ID: 15840382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of benzothiophene on male rats following short-term oral exposure.
    Poon R; Davis H; Lecavalier P; Liteplo R; Yagminas A; Chu I; Bihun C
    J Toxicol Environ Health; 1997 Jan; 50(1):53-65. PubMed ID: 9015132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hydrazine, phenelzine, and hydralazine treatment on rat hepatic and renal drug-metabolizing enzyme expression.
    Runge-Morris M; Feng Y; Zangar RC; Novak RF
    Drug Metab Dispos; 1996 Jul; 24(7):734-7. PubMed ID: 8818569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver.
    el Mouelhi M; Didolkar MS; Elias EG; Guengerich FP; Kauffman FC
    Cancer Res; 1987 Jan; 47(2):460-6. PubMed ID: 3024821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased renal drug metabolism in treadmill-exercised Fischer-344 male rats.
    Piatkowski TS; Day WW; Weiner M
    Drug Metab Dispos; 1993; 21(3):474-9. PubMed ID: 8100504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of four hypolipidaemic agents on the activity of drug-metabolizing enzymes in rat liver microsomes.
    Fournel S; Magdalou J; Batt AM; Siest G
    Int J Clin Pharmacol Res; 1983; 3(6):431-6. PubMed ID: 6432712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of vitamin A excess and T-2 toxin on the enzyme system activities of the second phase of xenobiotic metabolism in the rat liver].
    Kravchenko LV; Kon' IIa; Avren'eva LI; Tutel'ian VA
    Vopr Med Khim; 1984; 30(6):88-91. PubMed ID: 6442041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of hepatic drug metabolising system due to dimethylformamide (DMF).
    Fujishiro K; Imazu K; Makita Y; Inoue N
    Fukuoka Igaku Zasshi; 1996 Jul; 87(7):162-8. PubMed ID: 8776955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human.
    Kashfi K; McDougall CJ; Dannenberg AJ
    Clin Pharmacol Ther; 1995 Dec; 58(6):625-30. PubMed ID: 8529327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lead administration on developing rat kidney. I. Glutathione S-transferase isoenzymes.
    Moser R; Oberley TD; Daggett DA; Friedman AL; Johnson JA; Siegel FL
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):85-93. PubMed ID: 7878682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat.
    Sohn OS; Surace A; Fiala ES; Richie JP; Colosimo S; Zang E; Weisburger JH
    Xenobiotica; 1994 Feb; 24(2):119-27. PubMed ID: 8017087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of aspartame on the activity of rat liver xenobiotic-metabolizing enzymes.
    Tutelyan VA; Kravchenko LV; Kuzmina EE
    Drug Metab Dispos; 1990; 18(2):223-5. PubMed ID: 1971577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory methods for ten hepatic toxification/detoxification parameters.
    Kitchin KT
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):439-48. PubMed ID: 6422171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered enzyme activities of xenobiotic biotransformation in kidneys after subchronic administration of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) to rats.
    Heiskanen K; Linström-Seppä P; Haataja L; Vaittinen SL; Vartiainen T; Komulainen H
    Toxicology; 1995 Jun; 100(1-3):121-8. PubMed ID: 7624869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of human placental extract on hepatic drug metabolizing enzyme.
    Bishayee A; Banerjee KK; Chatterjee M
    Riv Eur Sci Med Farmacol; 1995; 17(1):19-26. PubMed ID: 8545551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective induction of phase II drug metabolizing enzyme activities by quinolines and isoquinolines.
    Le HT; Franklin MR
    Chem Biol Interact; 1997 Mar; 103(3):167-78. PubMed ID: 9134007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of folic acid on the activity of monooxygenase system, UDP-glucuronyl- and glutathione-S-transferase in the normal and regenerating rat liver].
    Bushma MI; Legon'kova LF; Lukienko PI
    Vopr Med Khim; 1987; 33(4):93-5. PubMed ID: 3116769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in response of glucuronide and glutathione conjugating enzymes to aflatoxin B1 and N-acetylaminofluorene in underfed rats.
    Rajpurohit R; Krishnaswamy K
    J Toxicol Environ Health; 1988; 24(1):103-9. PubMed ID: 3131540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of phenobarbital and its hydroxylated metabolites on drug-metabolizing enzymes during ontogenesis.
    Cresteil T; Mahu JL; Beaune P; Columelli S; Leroux JP
    Pediatr Pharmacol (New York); 1981; 1(4):331-40. PubMed ID: 6810295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of indomethacin on hepatic enzymes and histology and on serum indices of liver and kidney function in the rat.
    Falzon M; Whiting PH; Ewen SW; Milton AS; Burke MD
    Br J Exp Pathol; 1985 Oct; 66(5):527-34. PubMed ID: 3933537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.